News

12 Health Care Stocks Moving In Monday's After-Market Session
6 Jun 22
Movers
Adicet Bio Reports Emerging Data From ADI-001 Phase 1 Trial At The American Society Of Clinical Oncology Annual Meeting
6 Jun 22
Biotech, News, Events, General
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
5 Jun 22
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, General
70 Biggest Movers From Friday
31 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
41 Stocks Moving In Friday's Mid-Day Session
27 May 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
20 Stocks Moving in Friday's Pre-Market Session
27 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's After-Market Session
26 May 22
Movers
Adicet Bio Q1 EPS $0.10 Up From $(0.82) YoY
12 May 22
Earnings, News
Press releases
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
1 Jul 22
Press Releases
Adicet Bio to Present at Upcoming Investor Conferences
21 Jun 22
Press Releases
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
6 Jun 22
Press Releases
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3 Jun 22
Press Releases
Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)
26 May 22
Press Releases
Adicet Bio to Present at Upcoming Investor Conferences
18 May 22
Press Releases
Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates
12 May 22
Press Releases
Adicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies
5 May 22
Press Releases
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
4 May 22
Press Releases
Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
27 Apr 22
Press Releases
Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001
19 Apr 22
Press Releases
Adicet Bio to Participate in Upcoming Investor Conferences
7 Apr 22
Press Releases